Free EU-Wide Shipping on Orders Over €200
Free EU-Wide Shipping on Orders Over €200

This product is intended solely for use as a research chemical in vitro and laboratory experimentation by licensed, qualified professionals.
BPC-157 is a synthetic pentadecapeptide derived from human gastric juice. Extensively researched for tissue repair, wound healing, and cytoprotective properties. 10mg lyophilized powder, ≥99% purity.
| Molecular Formula | C62H98N16O22 |
| CAS | 137525-51-0 |
| Molar Mass | 1419.53 g/mol |
| Amino Acid Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Synonyms | Body Protection Compound-157, PL 14736, PL-10 |
| Solubility | Soluble in water |
| Organoleptic Profile | White powder |
| Physical Form | Lyophilized powder |
BPC-157 promotes angiogenesis (formation of new blood vessels) and accelerates healing of tendons, muscles, nerves, and ligaments. It modulates growth hormone receptor expression and enhances nitric oxide synthesis.
The peptide stabilizes gastric mucosa and promotes GI tract healing. Research indicates it influences the FAK-paxillin signaling cascade, which is central to cell migration and tissue remodeling.
BPC-157 demonstrates remarkable stability in gastric conditions, distinguishing it from many other bioactive peptides. This stability has made it valuable for studying gastrointestinal function, connective tissue biology, and regenerative processes.
BPC-157 is generally considered safe and well tolerated when used in research settings. However, as with any substance, there is a potential for side effects, particularly when used at high concentrations or for prolonged periods.
It's important to note that the safety and efficacy of BPC-157 for human use have not been fully established, and more research is needed to determine the long-term effects of this peptide complex.
BPC-157 (Body Protection Compound-157) is a 15-amino acid synthetic peptide derived from a naturally occurring protein found in human gastric juice. First isolated and characterized by Dr. Predrag Sikirić and colleagues, BPC-157 has been the subject of extensive preclinical research.
The peptide demonstrates remarkable stability in gastric conditions and has been studied in over 100 preclinical trials investigating tissue repair, wound healing, and cytoprotective properties.
Certificate of Analysis (COA) available upon request. Each batch is tested via HPLC for purity and Mass Spectrometry for identity confirmation.
All products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration or the European Medicines Agency. Products are not intended to diagnose, treat, cure, or prevent any disease.